Breaking News, Collaborations & Alliances

APL and CurifyLabs Partner for 3D-Printed Medicines

Aim to improve the administration of medicines to children and critically ill patients using novel 3D printing technology.

Author Image

By: Charlie Sternberg

Associate Editor

APL, a manufacturer of extemporaneous medicines and a contract development and manufacturing organization (CDMO) in Sweden, has joined forces with CurifyLabs, a Finnish health tech company creating personalized medicine manufacturing solutions, to improve the administration of medicines to children and critically ill patients using novel 3D printing technology.   Compared with traditional pharmaceutical processes, 3D printing can produce more personalized dosages and dosage forms, with flexibl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters